LEVOTHYROXINE SODIUM

Product NDC
70710-1833
11-digit product format
707101833
Labeler code
70710
Product ID
70710-1833_2ef84f1a-cf9a-4e93-8b2b-08bf75befd9e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
levothyroxine sodium
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Zydus Pharmaceuticals USA Inc.
Application
ANDA217066
Marketing category
ANDA
Marketing start
2024-11-01
Substance
LEVOTHYROXINE SODIUM ANHYDROUS
Active strength
100 ug/5mL
Pharmacologic classes
Thyroxine [CS], l-Thyroxine [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

openFDA Listing Details

Product ID
70710-1833_2ef84f1a-cf9a-4e93-8b2b-08bf75befd9e
Product type
HUMAN PRESCRIPTION DRUG
Finished product
Yes
Brand name base
LEVOTHYROXINE SODIUM
Generic name
levothyroxine sodium
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Marketing start
2024-11-01
Marketing category
ANDA
Application number
ANDA217066
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
Listing expiration
2026-12-31

Related Records

openFDA Active Ingredients

IngredientStrength
LEVOTHYROXINE SODIUM ANHYDROUS100 ug/5mL

openFDA Harmonized Identifiers

FieldValues
Unii054I36CPMN
Rxcui966219, 1115267, 1115269
Spl Set Idbf8a952c-f05b-4814-b55a-ed04be015269
Manufacturer NameZydus Pharmaceuticals USA Inc.

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
054I36CPMNLEVOTHYROXINE SODIUM ANHYDROUS55-03-8LEVOTHYROXINE SODIUM ANHYDROUS
9J765S329GLEVOTHYROXINE SODIUM6106-07-6levothyroxine sodium

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70710-1833-1707101833011 VIAL, SINGLE-DOSE in 1 CARTON (70710-1833-1) / 5 mL in 1 VIAL, SINGLE-DOSE2024-11-01NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
LEVOTHYROXINE SODIUMZydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited2025-09-16HUMAN PRESCRIPTION DRUG LABEL4